Research Areas

brain tissue slice

The NSW TRC has users of tissue both nationally and internationally. Some of the major research areas that utilise NSW TRC tissue include:

Alcohol-related Disorders

Professor Jillian Kril from The University of Sydney, in collaboration with Dr Greg Sutherland, is investigating neurogenesis in the alcoholic brain. Evidence from rodents suggests that chronic alcohol consumption impairs brain neurogenesis, but it is unclear whether this is the case in humans, or indeed whether significant neurogenesis occurs in older adult brains. Professor Kril is also the Director of the NSW Tissue Resource Centre.

Schizophrenia

Professor Cyndi Shannon-Weickert is a world renowned researcher currently based at Neuroscience Research Australia (NeuRA). Her research is focused on the molecular developmental neurobiology of schizophrenia. She is Australia's first Chair of Schizophrenia, a role supported by the Schizophrenia Research Institute.

Dr Kelly Newell is based at The University of Wollongong. Her research focuses on investigating causes of schizophrenia, specifically the role of the glutamatergic system, in the aetiology of schizophrenia, and how disruptions to this system affects other brain systems.

Neurological Disorders

Professor Glenda Halliday is a prominent researcher currently working on the pathogenesis of neurodegenerative diseases at the Neuroscience Research Australia (NeuRA). Her research has highlighted broader pathological involvement in Parkinson's disease and especially in dementia with Lewy bodies. She is also the Director of the Sydney Brain Bank, located at NeuRA.

Associate Professor Kay Double heads a research group at Neuroscience Research Australia (NeuRA) and investigates the neurochemistry of neurodegenerative disorders, with a particular focus on Parkinson's disease.

Motor Neuron Disease

Associate Professor Roger Pamphlett is based at the Discipline of Pathology at the University of Sydney. His research endeavours to find a genetic cause for motor neuron disease that will enable gene therapy to halt this condition. He is also the supervisor of the Australian Motor Neuron Disease DNA Bank.